ST
ALXN

Spot Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Spot Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$6.13M Buy
43,678
+6,422
+17% +$872K 0.78% 216
2017
Q2 		$4.53M Buy
+37,256
New +$4.34M 0.67% 262
2015
Q4 		– Sell
-2,796
Closed -$488K – 4520
2015
Q3 		$437K Buy
+2,796
New +$510K 0.03% 2145
2015
Q1 		– Sell
-30
Closed -$5.43K – 4686
2014
Q4 		$6K Hold
30
– – ﹤0.01% 3745
2014
Q3 		$5K Hold
30
– – ﹤0.01% 4141
2014
Q2 		$5K Hold
30
– – ﹤0.01% 4365
2014
Q1 		$5K Sell
30
-345
-92% -$54.9K ﹤0.01% 4016
2013
Q4 		$50K Buy
375
+191
+104% +$22.9K ﹤0.01% 3497
2013
Q3 		$21K Buy
+184
New +$20.2K ﹤0.01% 3772

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return